Husseini Manji

Global Therapeutic Area Head, Neuroscience, Johnson & Johnson

The Janssen Research & Development Neuroscience Therapeutic Area is headed by Husseini Manji, M.D., F.R.C.P.C. Husseini was previously Chief, Laboratory of Molecular Pathophysiology & Experimental Therapeutics, National Institutes of Health (NIH), and director of the NIH Mood and Anxiety Disorders Program, the largest program of its kind in the world. He is also a visiting professor at Duke University in Durham, North Carolina. He received his B.S. (Biochemistry) and M.D. from the University of British Columbia in Vancouver, Canada. Following residency training, he completed fellowship training at the National Institute of Mental Health (NIMH) and obtained extensive additional training in cellular and molecular biology at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).